Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829308 · ClinicalTrials.gov registry record · NA

SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers

A NA study, sponsored by Friends Research Institute.

Completed
Registry status
NA
Development phase
98
Enrollment target

NCT01829308: Completed NA study, sponsored by Friends Research Institute.

NCT01829308 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829308, a NA study, has completed, sponsored by Friends Research Institute.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target

Study Summary

The purpose of this study is to examine the implementation of two evidence-based intervention strategies of SBIRT (Generalist vs. Specialist) for adolescent alcohol, tobacco, other drug use, and HIV risk behaviors.

Primary Outcome

To examine the relative effectiveness of the Generalist condition v. the Specialist condition in terms of penetration of brief intervention (proportion of patients receiving brief intervention \[BI\] among those for whom a BI is indicated).

Interventions

  • BEHAVIORAL The brief interventions are delivered by behavioral health counselors (Specialist)
  • BEHAVIORAL The brief interventions are delivered by the primary care provider (Generalist)

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2013-04
Est. Completion 2017-12-31
Phase NA
Friends Research Institute

41 total trials

What the finished NCT01829308 record still lists

NCT01829308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which The brief interventions are delivered by behavioral health counselors (Specialist) is the first listed.

NCT01829308 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01829308 about?

NCT01829308 is a clinical study titled "SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers". The purpose of this study is to examine the implementation of two evidence-based intervention strategies of SBIRT (Generalist vs. Specialist) for adolescent alcohol, tobacco, other drug use, and HIV risk behaviors.

What is the current status of trial NCT01829308?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2013-04. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT01829308?

The interventions under investigation include: The brief interventions are delivered by behavioral health counselors (Specialist) (BEHAVIORAL), The brief interventions are delivered by the primary care provider (Generalist) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01829308?

This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01829308's enrollment target sits among peer trials

98 922nd of 2000 higher than 1,078 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02926729 · 98 participants · NA

    Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

  • NCT03382977 · 98 participants · Phase 1

    Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

  • NCT04577014 · 98 participants · Phase 1

    Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • NCT04817618 · 98 participants · Phase 3

    Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01829308, the US trial registry maintained by the National Library of Medicine. NCT01829308 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.